Latest From Lifecode Inc.
The last month of 2016 saw a final flurry of medtech M&A activity as companies rushed to seal deals before the New Year arrived. Medtech Insight's M&A data tracker recorded twice as many deals in December compared to the previous month, but that was not enough to boost the year's tally, which fell behind 2015.
Start-ups raised $1.8 billion in Q1 2016. Biopharma companies penned 33 alliances; 14 acquisitions were signed (11 in the biopharma industry).
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced January-February 2016.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in February 2016.
Drug Discovery Tools
- Drug Discovery Tools
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Therapeutic Areas
- Silicon Valley Biosystems Inc.
- North America
- Parent & Subsidiaries
- Lifecode Inc.
- Senior Management
Chris Rivest, CEO
Eugene Fratkin, PhD, SVP, R&D
Sivan Bercovici, PhD, CTO
Burt Demill, CCO
Dietrich Stephan, PhD, Scientist in Chief
Donna Hongo, PhD, Director, Clinical Lab and RA
Timothy Triche, PhD, MD, Lab Director
- Contact Info
Phone: (650) 265-6909
348 Hatch Dr.
Foster City, CA 94404
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.